Apellis Pharmaceuticals Inc
 $520,065,549 Kezar Life Sciences, Inc.
 $1,373,335 Liquidia Technologies Inc
 $6,864,882 Amylyx Pharmaceuticals, Inc.
 $0 Apellis Pharmaceuticals Inc
 $520,065,549 Kezar Life Sciences, Inc.
 $1,373,335 Liquidia Technologies Inc
 $6,864,882 Amylyx Pharmaceuticals, Inc.
 $0